Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 30, 2023, titled " USFDA concludes inspection at Solara s Visakhapatnam (Vizag) facility with zero 483 inspectional observations. ".
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 30, 2023, titled " USFDA concludes inspection at Solara s Visakhapatnam (Vizag) facility with zero 483 inspectional observations. ".